IP Library Granted Patent US 12,734,730
Granted Patent B2
US 12,734,730 · App. 18/660,496 · Granted Sep 15, 2026

Hybrid method of forming microstructure array molds, methods of making microstructure arrays, and methods of use

Inventors: Ashutosh Shastry (Santa Clara, CA); Wesley Chang (Fremont, CA); Parminder Singh (Union City, CA)
Assignee: Panther Life Sciences Corporation
B29C33/3857A61M37/0015G03F7/0002G03F7/0015G03F7/0382G03F7/0392G03F7/0755G03F7/2016A61M2037/0053B29L2031/757
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,734,730
App. No.
18/660,496
Granted
Sep 15, 2026
Kind
B2
Abstract

A method of forming a master mold ( 52 ), comprising: a) forming a plurality of microstructure portions ( 42 ) in a substrate formed of a first material by a first micromachining process, each microstructure portion comprising a shaft ( 40 ) and a distal tip ( 38 ); b) preparing a negative mold ( 46 ) of the plurality of microstructure portions, wherein the mold is formed of a second material and comprises a plurality of cavities ( 48 ) corresponding to each microstructure portion in the plurality of microstructure portions ( 42 ); c) electroplating a metal ( 50 ) onto the negative mold to fill each cavity in the plurality of cavities and to form a base layer ( 54 ) extending from the negative mold; d) forming a proximal section ( 56 ) for each of the microstructures in the base layer using a second micromachining process (e.g. mechanical micromachining); and e) before or after said step d), removing the negative mold from the metal to form a master mold.

Claims (46)

1 . A method of forming a master mold, comprising:

a) forming a plurality of microstructure portions in a substrate formed of a first material by a first micromachining process, each microstructure portion comprising a shaft and a distal tip;

b) preparing a negative mold of the plurality of microstructure portions, wherein the mold is formed of a second material and comprises a plurality of cavities corresponding to each microstructure portion in the plurality of microstructure portions;

c) electroplating a metal onto the negative mold to fill each cavity in the plurality of cavities and to form a base layer extending from the negative mold;

d) forming a proximal section for each of the microstructures in the base layer using a second micromachining process; and

e) before or after said step d), removing the negative mold from the metal to form a master mold.

2 . The method of claim 1 , wherein the second micromachining process is a mechanical micromachining process.

3 . The method of claim 1 , wherein the first material is selected from silicon and a positive photoresist material.

4 . The method of claim 1 , wherein said first micromachining process comprises a photolithography process.

5 . The method of claim 4 , wherein said photolithography comprises:

1) Applying a layer of photoresist on the first material;

2) Applying a masking material onto the photoresist layer, wherein the masking material covers at least a portion of the photoresist layer;

3) Curing the portion of the photoresist layer not covered by the masking material;

4) Isotropic etching the substrate to create the distal tip section;

5) Etching the substrate to create the shaft portion;

6) Wet thermal oxidizing the microstructures; and

7) Isotropic wet etching the microstructures.

6 . The method of claim 5 , wherein the first material is silicon, and the method further comprises forming a layer of silicon dioxide on the silicon substrate using a thermal oxidation process prior to step 1.

7 . The method of claim 5 , wherein the thermal oxidation process in step 1 is a wet thermal oxidation process.

8 . The method of claim 5 , wherein the photoresist material is an epoxy-based negative photoresist.

9 . The method of claim 8 , wherein the photoresist material is SU-8.

10 . The method of claim 5 , wherein the masking material comprises a plurality of apertures, wherein the photoresist layer exposed by the apertures is cured in step 3.

11 . The method of claim 5 , further comprising:

removing the masking material and any uncured photoresist material after step 3.

12 . The method of claim 11 , wherein the masking material and uncured photoresist are removed using a solvent.

13 . The method of claim 5 , wherein the etching of step 5 comprises anisotropic etching.

14 . The method of claim 5 , wherein step 5 comprises deep reactive-ion etching.

15 . The method of claim 5 , further comprising:

prior to step 1, cleaning a polymeric material.

16 . The method of claim 15 , wherein said cleaning comprises chemical cleaning.

17 . The method of claim 16 , wherein the chemical cleaning comprises an RCA cleaning process.

18 . The method of claim 5 , wherein step 4 and/or step 5 comprises plasma etching.

19 . The method of claim 18 , wherein the plasma etching comprises a plasma gas selected from SF6, carbon tetrachloride, oxygen, and CHF 3 .

20 . The method of claim 5 , further comprising removing any remaining photoresist from the first material after step 5.

21 . The method of claim 1 , wherein the second material is one of a polymeric material and a silicon material.

22 . The method of claim 21 , wherein the second material is selected from the group consisting of polydimethylsiloxane (PDMS), polycarbonate, polyetherimide, and polyethylene terephthalate.

23 . The method of claim 1 , wherein the electroplating metal is selected from copper, nickel, chromium, and gold.

24 . The method of claim 1 , wherein the proximal section is micromachined to have a funnel or pyramidal shape.

25 . A method of forming a casting mold comprising:

preparing a negative mold of the master mold formed in claim 1 .

26 . A method of preparing a microstructure array, comprising:

dispensing a polymer matrix solution or suspension comprising at least one therapeutic agent on a casting mold of claim 25 ;

drying the polymer matrix solution;

dispensing a polymer matrix backing solution on the casting mold;

drying the polymer matrix backing solution to form the microstructure array; and

demolding the microstructure array.

Assignments (8)
CHANGE OF NAME Recorded Dec 3, 2024
From: CORIUM PHARMA SOLUTIONS, INC.
To: CORIUM INNOVATIONS, INC.
Reel/Frame 069479/0197 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2024
From: CORIUM, INC.
To: CORIUM PHARMA SOLUTIONS, INC.
Reel/Frame 069472/0291 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2024
From: CORIUM INNOVATIONS, INC.
To: PANTHER LIFE SCIENCES CORPORATION
Reel/Frame 069477/0743 →
CHANGE OF NAME Recorded Dec 3, 2024
From: CORIUM INTERNATIONAL, INC.
To: CORIUM, INC.
Reel/Frame 069478/0458 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2024
From: SHASTRY, ASHUTOSH; CHANG, WESLEY; SINGH, PARMINDER
To: CORIUM INTERNATIONAL, INC.
Reel/Frame 069472/0203 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2024
From: CORIUM, INC.
To: CORIUM PHARMA SOLUTIONS, INC.
Reel/Frame 067757/0333 →
CHANGE OF NAME Recorded Jun 18, 2024
From: CORIUM INTERNATIONAL, INC.
To: CORIUM, INC.
Reel/Frame 067776/0306 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2024
From: SHASTRY, ASHUTOSH; CHANG, WESLEY; SINGH, PARMINDER
To: CORIUM INTERNATIONAL, INC.
Reel/Frame 067756/0947 →
Continuity (3)
Continuation 17255420 · Jun 25, 2019
Provisional Application 62689640 · Jun 25, 2018
Related Publication 20250114981A1 · Apr 10, 2025
References Cited (74)
US 3964482A · Gerstel et al. · 1976 [cited by applicant]
US 6219574B1 · Cormier et al. · 2001 [cited by applicant]
US 6451240B1 · Sherman et al. · 2002 [cited by applicant]
US 6652478B1 · Gartstein et al. · 2003 [cited by applicant]
US 6849558B2 · Schaper · 2005 [cited by applicant]
US 6945952B2 · Kwon · 2005 [cited by applicant]
US 7763203B2 · Arias et al. · 2010 [cited by applicant]
US 7785301B2 · Yuzhakov · 2010 [cited by applicant]
US 8603384B2 · Lüttge et al. · 2013 [cited by applicant]
US 9597822B2 · Mitamura · 2017 [cited by applicant]
US 11179553B2 · Kendall et al. · 2021 [cited by applicant]
US 20020082543A1 · Park et al. · 2002 [cited by applicant]
US 20030228759A1 · Uehara et al. · 2003 [cited by applicant]
US 20040007796A1 · Lastovich · 2004 [cited by examiner]
US 20040087992A1 · Gartstein et al. · 2004 [cited by applicant]
US 20050197308A1 · Dalton et al. · 2005 [cited by applicant]
US 20080063866A1 · Allen et al. · 2008 [cited by applicant]
US 20080269685A1 · Singh et al. · 2008 [cited by applicant]
US 20100304064A1 · Huttner · 2010 [cited by applicant]
US 20110006458A1 · Sagi et al. · 2011 [cited by applicant]
US 20110192562A1 · Motoi et al. · 2011 [cited by applicant]
US 20110276027A1 · Trautman et al. · 2011 [cited by applicant]
US 20110276028A1 · Singh et al. · 2011 [cited by applicant]
US 20130292868A1 · Singh et al. · 2013 [cited by applicant]
US 20140180201A1 · Ding et al. · 2014 [cited by applicant]
US 20140272101A1 · Chen et al. · 2014 [cited by applicant]
US 20140276366A1 · Bourne et al. · 2014 [cited by applicant]
US 20140276580A1 · Le et al. · 2014 [cited by applicant]
US 20170095947A1 · Ogawa et al. · 2017 [cited by applicant]
US 20170274196A1 · Nordon et al. · 2017 [cited by applicant]
US 20180250851A1 · Ogawa et al. · 2018 [cited by applicant]
US 20200197679A1 · Li et al. · 2020 [cited by applicant]
US 20210276228A1 · Shastry et al. · 2021 [cited by applicant]
CN 1623515A · 2005 [cited by applicant]
CN 102026910A · 2011 [cited by applicant]
CN 102202723A · 2011 [cited by applicant]
CN 104067171A · 2014 [cited by applicant]
CN 105498082A · 2016 [cited by applicant]
CN 107538652A · 2018 [cited by applicant]
EP 1377338A2 · 2004 [cited by applicant]
EP 2155418A1 · 2010 [cited by applicant]
JP 2003071849A · 2003 [cited by applicant]
JP 2007118422A · 2007 [cited by applicant]
JP 2009061745A · 2009 [cited by applicant]
JP 2009184117A · 2009 [cited by applicant]
JP 2011083387A · 2011 [cited by applicant]
JP 2016030072A · 2016 [cited by applicant]
JP 2016510375A · 2016 [cited by applicant]
JP 2017071094A · 2017 [cited by applicant]
KR 20130005353A · 2013 [cited by applicant]
WO WO2002053193A2 · 2002 [cited by applicant]
WO WO2002072189A2 · 2002 [cited by applicant]
WO WO2010096072A1 · 2010 [cited by applicant]
WO WO2012054582A2 · 2012 [cited by applicant]
WO WO2012153266A2 · 2012 [cited by applicant]
WO WO2016033540A1 · 2016 [cited by applicant]
WO WO2016036866A1 · 2016 [cited by applicant]
WO WO2016149152A1 · 2016 [cited by applicant]
WO WO2017056895A1 · 2017 [cited by applicant]
WO WO2017116076A1 · 2017 [cited by applicant]
JP Application No. 2020-571757, Office Action dated Jan. 30, 2023; Applicant Corium Pharma Solutions, Inc.; 9 pages with English translation. [cited by applicant]
JP Application No. 2020-571757, Office Action dated May 30, 2023; Applicant Corium Pharma Solutions, Inc.; 9 pages with English translation. [cited by applicant]
Park et al. “Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery.” Journal of controlled release. May 5, 2005;104(1):51-66. [cited by applicant]
Park et al. “Polymer microneedles for controlled-release drug delivery.” Pharmaceutical research. May 2006; 23:1008-1019. [cited by applicant]
Park et al. “Polymer particle-based micromolding to fabricate novel microstructures.” Biomedical Microdevices. Apr. 2007;9:223-234. [cited by applicant]
PCT Application No. PCT/US2019/039028, International Preliminary Report on Patentability dated Dec. 29, 2020; Applicant Corium, Inc.; 11 pages. [cited by applicant]
PCT Application No. PCT/US2019/039028, International Search Report and Written Opinion dated Sep. 13, 2019; Applicant Corium, Inc.; 6 pages. [cited by applicant]
Pharmacosmos, “Dextran 1,” [online] [retrieved on Feb. 10, 2025]. Retrieved from the Internet: URL: [https://dextran.com/product-categories/pharmaceutical-quality-dextran/dextran-1/], 6 pages. [cited by applicant]
Pharmacosmos, “Dextran 10,” [online] [retrieved on Feb. 10, 2025]. Retrieved from the Internet: URL: [https://dextran.com/product-categories/pharmaceutical-quality-dextran/dextran-10]/, 4 pages. [cited by applicant]
Pharmacosmos, “Dextran 20,” [online] [retrieved on Feb. 10, 2025]. Retrieved from the Internet: URL: [https://dextran.com/product-categories/pharmaceutical-quality-dextran/dextran-20/], 4 pages. [cited by applicant]
Pharmacosmos, “Dextran 40,” [online] [retrieved on Feb. 10, 2025]. Retrieved from the Internet: URL: [https://dextran.com/product-categories/pharmaceutical-quality-dextran/dextran-40/], 8 pages. [cited by applicant]
Pharmacosmos, “Dextran 70,” [online] [retrieved on Feb. 10, 2025]. Retrieved from the Internet: URL: [https://dextran.com/product-categories/pharmaceutical-quality-dextran/dextran-70/], 8 pages. [cited by applicant]
Pharmacosmos, “Dextran 75.” [online] [retrieved on Feb. 10, 2025]. Retrieved from the Internet: [URL: https://go.drugbank.com/salts/DBSALT002685], 10 pages. [cited by applicant]
U.S. Appl. No. 17/255,420, Office Action dated Aug. 25, 2023; Inventor Shastry, Ashutosh et al.; 7 pages. [cited by applicant]